The control of hypertension in pregnancy study pilot trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 114, Issue 6, 2007, Pages

  Magee, L A ^a,l   Von Dadelszen, P ^a   Chan, S ^b   Gafni, A ^c   Gruslin, A ^d   Helewa, M ^e   Hewson, S ^b   Kavuma, E ^b   Lee, S K ^f   Logan, A G ^g   McKay, D ^b   Moutquin, J M ^h   Ohlsson, A ⁱ   Rey, E ^j   Ross, S ^k   Singer, J ^a   Willan, A R ⁱ   Hannah, M E ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITÉ DE SHERBROOKE   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITÉ DE MONTRÉAL   (Canada)

^k UNIVERSITY OF CALGARY   (Canada)

^l CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

more..

Author keywords

Antihypertensive therapy; Hypertension; Maternal outcome; Perinatal outcome; Pregnancy

Indexed keywords

ANTIHYPERTENSIVE AGENT; LABETALOL; METHYLDOPA; NIFEDIPINE;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; AUSTRALIA; BIRTH WEIGHT; BLOOD PRESSURE REGULATION; CANADA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG DOSE REDUCTION; FEMALE; FETUS OUTCOME; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTICENTER STUDY; NEW ZEALAND; NEWBORN DISEASE; NEWBORN INTENSIVE CARE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PILOT STUDY; PREGNANCY COMPLICATION; PREMATURE LABOR; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM;

ADULT; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; LABETALOL; PATIENT SATISFACTION; PILOT PROJECTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 34249109989     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01315.x     Document Type: Article

References (30)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000 183 : S1 22.
2. Brown MA, Hague WM, Higgins J, Lowe S, McCowan L, Oats J, et al. The detection, investigation and management of hypertension in pregnancy: executive summary. Aust N Z J Obstet Gynaecol 2000 40 : 133 8.
3. Rey E, LeLorier J, Burgess E, Lange IR, Leduc L. Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy. CMAJ 1997 157 : 1245 54.
4. Blake S, MacDonald D. The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment. Br J Obstet Gynaecol 1991 98 : 244 8.
5. Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG 2000 107 : 792 4.
6. Catalano D, Ercolano S, Pollio F, Ascione L, Russo C, DeSanti B, et al. Valuazione della monoterapia con nifedipina nel management della gestosi EPH [Evaluation of nifedipine monotherapy in the management of pregnancy hypertension]. Giornale Italiono Di Ostebricia e Ginecologia 1997 6 : 373 5.
7. Elhassan EM, Mirghani OA, Habour AB, Adam I. Methyldopa versus no drug treatment in the management of mild pre-eclampsia. East Afr Med J 2002 79 : 172 5.
8. Gruppo di Studio Ipertensione in Gravidanza. Nifedipine versus expectant management in mild to moderate hypertension in pregnancy. Br J Obstet Gynaecol 1998 105 : 718 22.
9. Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999 318 : 1332 6.
10. Odendaal HJ, Schabort I, Pattinson RC. Prazosin for the Treatment of Hypertension in Pregnancy: A Randomized Control Trial. Oxford Database of Perinatal Trials 1991; version 1.2 (disk issue 6).
11. ICH note for guidance on good clinical practice (CPMP/ICH/13595). 2002 www.emea.eu.int/pdfs/human/ich/013595en.pdf Accessed 6 November 2006.
12. Helewa ME, Burrows RF, Smith J, Williams K, Brain P, Rabkin SW. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997 157 : 715 25.
13. Butters L. Essential hypertension in pregnancy. Nurs Times 1990 86 : 53.
14. Churchill D, Bayliss H, Beevers G. Fetal growth restriction. Lancet 2000 355 : 1366 7.
15. Easterling TR, Carr DB, Brateng D, Diederichs C, Schmucker B. Treatment of hypertension in pregnancy: effect of atenolol on maternal disease, preterm delivery, and fetal growth. Obstet Gynecol 2001 98 : 427 33.
16. Lydakis C, Lip GYH, Beevers M, Beevers DG. Atenolol and fetal growth in pregnancies complicated by hypertension. Am J Hypertens 1999 12 : 541 7.
17. Hodnett ED, Hannah ME, Weston JA, Ohlsson A, Myhr TL, Wang EE, et al. Women's evaluations of induction of labor versus expectant management for prelabor rupture of the membranes at term. TermPROM Study Group. Birth 1997 24 : 214 20.
18. Kramer MS, Platt RW, Wen SW, Joseph KS, Allen A, Abrahamowicz M, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 2001 108 : E35.
19. WinBUGS Version 1.2 User Manual. Cambridge : MRC Biostatistics Unit, 1999.
20. von Dadelszen P, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002 24 : 941 5.
21. von Dadelszen P, Ornstein MP, Bull SB, Logan AG, Koren G, Magee LA. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000 355 : 87 92.
22. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2001 CD002252.
23. von Dadelszen P, Magee LA, Lee SK, Stewart SD, Simone C, Koren G, et al. Activated protein C in normal human pregnancy and pregnancies complicated by severe preeclampsia: a therapeutic opportunity? Crit Care Med 2002 30 : 1883 92.
24. Golara M, Jones C, Randhawa M, Shennan AH. Inflationary oscillometric blood pressure monitoring: validation of the OMRON-MIT. Blood Press Monit 2002 7 : 325 8.
25. Reinders A, Cuckson AC, Lee JT, Shennan AH. An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A. BJOG 2005 112 : 915 20.
26. Magee LA, von Dadelszen P, Bohun CM, Rey E, El Zibdeh M, Stalker S, et al. Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study. J Obstet Gynaecol Can 2003 25 : 372 82.
27. Shennan AT, Dunn MS, Ohlsson A, Lennox K, Hoskins EM. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics 1988 82 : 527 32.
28. Papile LA, Munsick-Bruno G, Schaefer A. Relationship of cerebral intraventricular hemorrhage and early childhood neurologic handicaps. J Pediatr 1983 103 : 273 7.
29. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 1978 187 : 1 7.
30. An international classification of retinopathy of prematurity. Pediatrics 1984 74 : 127 33.